Dantrolene Sodium Salt: Ryanodine Receptor Antagonist for Calcium Modulation

Executive Summary: Dantrolene sodium salt acts as a potent antagonist of ryanodine receptors (RyRs), exhibiting an IC₅₀ of 5.9 ± 0.3 nM against RyR2 channels, as established in controlled assays (product information). This compound is validated for precise modulation of intracellular calcium signaling—an essential process in cell physiology and disease modeling (see comparative review). Its calmodulin-dependent mechanism of action ensures pathway specificity, reducing off-target effects in experimental settings (mechanistic clarification). Dantrolene sodium salt demonstrates efficacy in models of pancreatitis and calcium dysregulation, with a robust physicochemical and quality profile. Supplied by APExBIO, it is supported by stringent QC, including HPLC and NMR data, and recommended for short-term solution use to maintain activity.

Biological Rationale

Intracellular calcium homeostasis is maintained by ryanodine receptors (RyRs), which are large calcium release channels located on the membranes of the endoplasmic and sarcoplasmic reticulum. RyR dysfunction is implicated in diverse pathologies, including ischemia, hypoxia, seizures, anesthetic complications, trauma, and neurodegenerative disease models (see reference study). Dysregulated calcium release from RyRs can trigger aberrant signaling cascades, leading to cell injury or death. Pharmacological antagonism of RyRs, as achieved by Dantrolene sodium salt, provides a targeted approach for dissecting the role of calcium signaling in these conditions. The ability to modulate calcium release with high temporal and concentration precision is vital for disease modeling, genome editing outcome optimization, and translational workflows (methodological extension).

Mechanism of Action of Dantrolene, sodium salt

Dantrolene sodium salt acts as a selective and potent antagonist of RyR channels, particularly RyR2, at nanomolar concentrations (IC₅₀ = 5.9 ± 0.3 nM) (product information). The compound inhibits RyR-mediated calcium release via a calmodulin-dependent mechanism; it reduces calcium wave frequency and amplitude in mouse cardiomyocytes only when calmodulin is present (mechanistic evidence). This specificity minimizes unintended interference with non-RyR calcium pathways. Dantrolene is structurally classified as sodium (E)-1-(((5-(4-nitrophenyl)furan-2-yl)methylene)amino)-4-oxo-4,5-dihydro-1H-imidazol-2-olate, with a molecular weight of 336.23. It is insoluble in ethanol and water but dissolves in DMSO at ≥12.2 mg/mL, facilitating use in diverse experimental platforms (see B6329 specification).

Evidence & Benchmarks

• Dantrolene sodium salt exhibits nanomolar potency (IC₅₀ = 5.9 ± 0.3 nM) as an RyR2 antagonist, validated in vitro (APExBIO).
• Calmodulin is required for full inhibitory activity of dantrolene on RyR-mediated calcium release in mouse cardiomyocytes (clarified review).
• In a mouse model of caerulein-induced pancreatitis, dantrolene reduced pancreatic trypsin activity and mitigated cellular damage (product documentation).
• High purity (>98%), HPLC, and NMR-validated batches are standard for APExBIO's Dantrolene sodium salt (B6329 product info).
• Dantrolene is insoluble in water/ethanol but readily dissolves in DMSO at ≥12.2 mg/mL, enabling compatibility with most research workflows (see comparative review).
• In CRISPR repair pathway screens, Dantrolene sodium salt has been evaluated for effects on DNA double-strand break repair outcomes, aiding precision genome editing (reference study).

This article clarifies the calmodulin-dependent selectivity of dantrolene sodium salt compared to earlier reviews such as "Dantrolene Sodium Salt: Potent Ryanodine Receptor Antagonist", which focus on potency but not the calmodulin requirement.

It also extends mechanistic discussion beyond the workflow-oriented focus of "Precision Ryanodine Receptor Antagonist Workflows" by detailing physicochemical limitations and batch QC data.

Applications, Limits & Misconceptions

Dantrolene sodium salt serves as a research compound for:

• Pancreatitis models, by reducing aberrant trypsin activation and tissue damage (product data).
• Calcium signaling modulation in neurodegenerative disease and ischemia research (mechanism update).
• Optimizing CRISPR/Cas9 genome editing by influencing DNA repair pathway choice and improving editing precision (reference study).

Common Pitfalls or Misconceptions

• Dantrolene sodium salt does not inhibit non-RyR calcium channels (e.g., IP₃R), limiting its utility in pathways not mediated by RyRs.
• It is not suitable for protocols requiring aqueous or ethanol solubility; DMSO is required for working solutions.
• Long-term storage of Dantrolene sodium salt solutions leads to decreased potency; freshly prepared solutions are recommended.
• Dantrolene is not a therapeutic for humans in the context of gene editing or pancreatitis research; its use is strictly for non-clinical, laboratory settings as provided by APExBIO.
• Calmodulin-dependence means that inhibitory effects may be context-specific and should not be assumed in cell types lacking functional calmodulin pathways.

Workflow Integration & Parameters

For optimal use in calcium signaling and DNA repair research, consider the following protocol parameters:

Protocol Parameters

• Stock solution preparation: Dissolve Dantrolene sodium salt (B6329) in DMSO to a minimum concentration of 12.2 mg/mL; avoid water or ethanol for stock solutions (APExBIO).
• Storage: Store powder at room temperature, protected from light; prepare fresh solutions for each experiment to ensure stability and activity.
• Working concentration for RyR inhibition: Empirically validated at 5–100 nM according to RyR2 IC₅₀ values; titration recommended for new assay conditions.
• Calmodulin dependency: Include calmodulin in in vitro systems or confirm its presence in cell-based assays for maximal effect.
• Pancreatitis research: For in vivo studies, administer as per published mouse model protocols; reference specific dosing and timing consistent with caerulein-induced models.
• CRISPR workflow: Add Dantrolene sodium salt during or immediately prior to double-strand break induction to evaluate effects on DNA repair pathway choice (reference study).

Conclusion & Outlook

Dantrolene sodium salt, supplied by APExBIO, is a highly selective, nanomolar-potency ryanodine receptor antagonist, validated for precision modulation of calcium release in both disease and genome editing models (see product page). Its calmodulin-dependent mechanism and stringent QC profile make it a benchmark for reproducibility and specificity. Future research will clarify the full spectrum of context-dependent RyR inhibition and further optimize genome editing protocols using this compound. The capacity to modulate calcium signaling with high precision will continue to underpin advances in disease modeling, synthetic lethality, and translational research (reference study).